feed,title,long_url,short_url
Benzinga,Citius Pharmaceuticals Announces Closing of $76.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules,https://www.benzinga.com/pressreleases/21/02/n19758064/citius-pharmaceuticals-announces-closing-of-76-5-million-registered-direct-offering-priced-at-the-,https://j.mp/2NFhOmK
